Accuracy of self-reported family history of cancer, mutation status and tumor characteristics in patients with early onset breast cancer

References

• The National Board of Health and Welfare [Internet]. Cancer incidence in Sweden 2014, 2015. Available from: http://www.socialstyrelsen.se/register/halsodataregister/cancerregistret
   Google Scholar
• Farouk O, Ebrahim MA, Senbel A, et al. Breast cancer characteristics in very young Egyptian women </=35 years. Breast Cancer (Dove Med Press). 2016;8:53–58.
   PubMed Web of Science ®Google Scholar
• Liukkonen S, Leidenius M, Saarto T, et al. Breast cancer in very young women. Eur J Surg Oncol. 2011;37:1030–1037.
   PubMed Web of Science ®Google Scholar
• Lalloo F, Evans DG. Familial breast cancer. Clin Genet. 2012;82:105–114.
   PubMed Web of Science ®Google Scholar
• Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet. 2003;72:1117–1130.
   PubMed Web of Science ®Google Scholar
• Apostolou P, Fostira F. Hereditary breast cancer: the era of new susceptibility genes. BioMed Res Int. 2013;2013:747318.
   PubMed Web of Science ®Google Scholar
• Larsen MJ, Thomassen M, Gerdes AM, et al. Hereditary breast cancer: clinical, pathological and molecular characteristics. Breast Cancer (Auckl). 2014;8:145–155.
   PubMedGoogle Scholar
• Llort G, Chirivella I, Morales R, et al. SEOM clinical guidelines in Hereditary Breast and ovarian cancer. Clin Transl Oncol. 2015;17:956–961.
   PubMed Web of Science ®Google Scholar
• Partridge AH, Pagani O, Abulkhair O, et al. First international consensus guidelines for breast cancer in young women (BCY1). Breast. 2014;23:209–220.
   PubMed Web of Science ®Google Scholar
• Ziogas A, Anton-Culver H. Validation of family history data in cancer family registries. Am J Prev Med. 2003;24:190–198.
   PubMed Web of Science ®Google Scholar
• Henriksson K, Olsson H, Kristoffersson U. The need for oncogenetic counselling. Ten years’ experience of a regional oncogenetic clinic. Acta Oncol. 2004;43:637–649.
   PubMed Web of Science ®Google Scholar
• Barlow L, Westergren K, Holmberg L, et al. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol. 2009;48:27–33.
   PubMed Web of Science ®Google Scholar
• Hakansson S, Johannsson O, Johansson U, et al. Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer. Am J Hum Genet. 1997;60:1068–1078.
   PubMed Web of Science ®Google Scholar
• Borg A, Haile RW, Malone KE, et al. Characterization of BRCA1 and BRCA2 deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study. Hum Mutat. 2010;31:E1200–E1240.
   PubMed Web of Science ®Google Scholar
• Foxcroft LM, Evans EB, Porter AJ. The diagnosis of breast cancer in women younger than 40. Breast. 2004;13:297–306.
   PubMed Web of Science ®Google Scholar
• McAree B, O'Donnell ME, Spence A, et al. Breast cancer in women under 40 years of age: a series of 57 cases from Northern Ireland. Breast. 2010;19:97–104.
   PubMed Web of Science ®Google Scholar
• Loman N, Johannsson O, Kristoffersson U, et al. Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. J Natl Cancer Inst. 2001;93:1215–1223.
   PubMedGoogle Scholar
• Verkooijen HM, Fioretta G, Chappuis PO, et al. Set-up of a population-based familial breast cancer registry in Geneva, Switzerland: validation of first results. Annal Oncol. 2004;15:350–353.
   PubMed Web of Science ®Google Scholar
• Foulkes WD. Inherited susceptibility to common cancers. N Engl J Med. 2008;359:2143–2153.
   PubMed Web of Science ®Google Scholar
• Oosterwijk JC, de Vries J, Mourits MJ, et al. Genetic testing and familial implications in breast-ovarian cancer families. Maturitas. 2014;78:252–257.
   PubMed Web of Science ®Google Scholar
• Nilsson MP, Hartman L, Idvall I, et al. Long-term prognosis of early-onset breast cancer in a population-based cohort with a known BRCA1/2 mutation status. Breast Cancer Res Treat. 2014;144:133–142.
   PubMed Web of Science ®Google Scholar
• Bayraktar S, Amendola L, Gutierrez-Barrera AM, et al. Clinicopathologic characteristics of breast cancer in BRCA-carriers and non-carriers in women 35 years of age or less. Breast. 2014;23:770–774.
   PubMed Web of Science ®Google Scholar
• Regionala cancercentrum i samverkan [Internet]. Bröstcancer Nationellt vårdprogram. 2014. Available from: http://www.swebcg.se/Files/Docs/NatVP_Brostcancer_2014-11-11_final[1].pdf
   Google Scholar
• Rosenberg SM, Ruddy KJ, Tamimi RM, et al. BRCA1 and BRCA2 Mutation testing in young women with breast cancer. JAMA Oncol. 2016;2:730–736.
   PubMed Web of Science ®Google Scholar
• Nilsson MP, Winter C, Kristoffersson U, et al. Efficacy versus effectiveness of clinical genetic testing criteria for BRCA1 and BRCA2 hereditary mutations in incident breast cancer. Fam Cancer. 2017;16:187–193.
   PubMed Web of Science ®Google Scholar